Ellahi Aayat, Shaikh Fahd Niaz, Kashif Haider, Khan Hamna, Ali Eman, Nasim Bushra, Adil Mariam, Huda Zunera, Liaquat Ayesha, Arshad Muhammad Sameer
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Ann Med Surg (Lond). 2022 Sep 3;81:104477. doi: 10.1016/j.amsu.2022.104477. eCollection 2022 Sep.
Thoracoabdominal aortic aneurysms (TAAAs) are associated with significant comorbidities. The aim of our study is to compare the outcomes of open repair versus endovascular repair of TAAAs.
A thorough literature search was conducted on MEDLINE, Embase, and Cochrane Central databases. The analysis included observational studies comparing the outcomes of surgical vs endovascular aneurysm repair (EVAR) of TAAA. Mortality, spinal cord ischemia (SCI), renal failure, stroke, paraplegia, and respiratory and cardiac problems were all included in the studies. The results were provided as relative risks (RRs) with 95% confidence intervals (CIs). These were then aggregated using an inverse variance weighted random-effects model, and the pooled analysis was displayed using forest plots.
This meta-analysis compromising of twelve studies revealed significant results, favoring endovascular repair versus open surgery for all-cause mortality (HR = 1.91; 95% CI: 1.68-2.18; P < 0.00001), SCI (HR = 1.62; 95% CI: 1.18-2.21; P = 0.003), respiratory complications (HR = 2.22; 95% CI: 1.78-2.77; P < 0.00001), and cardiac complications (HR = 1.66; 95% CI: 1.38-2.00; P < 0.00001). Upon subgroup analysis based on propensity matched, results were consistent and significant for the outcomes of all-cause mortality, cardiac complications, and respiratory complications. For the propensity unmatched subgroup, the incidence of all-cause mortality, SCI, respiratory complications, and cardiac complications were lower among endovascular repair cohort.
Current evidence supports the use of endovascular repair over open surgery. However, there is a need to conduct dedicated randomized controlled trials to effectively compare and determine the benefits and risk of both strategies.
胸腹主动脉瘤(TAAAs)与严重的合并症相关。我们研究的目的是比较胸腹主动脉瘤开放修复与血管腔内修复的结果。
对MEDLINE、Embase和Cochrane Central数据库进行了全面的文献检索。分析包括比较胸腹主动脉瘤手术与血管腔内动脉瘤修复(EVAR)结果的观察性研究。研究纳入了死亡率、脊髓缺血(SCI)、肾衰竭、中风、截瘫以及呼吸和心脏问题。结果以相对风险(RRs)及95%置信区间(CIs)的形式呈现。然后使用逆方差加权随机效应模型进行汇总,并使用森林图展示合并分析结果。
这项包含12项研究的荟萃分析显示了显著结果,在全因死亡率(HR = 1.91;95% CI:1.68 - 2.18;P < 0.00001)、脊髓缺血(HR = 1.62;95% CI:1.18 - 2.21;P = 0.003)、呼吸并发症(HR = 2.22;95% CI:1.78 - 2.77;P < 0.00001)和心脏并发症(HR = 1.66;95% CI:1.38 - 2.00;P < 0.00001)方面,血管腔内修复优于开放手术。基于倾向匹配的亚组分析显示,全因死亡率、心脏并发症和呼吸并发症的结果一致且具有显著性。对于倾向不匹配亚组,血管腔内修复队列中的全因死亡率、脊髓缺血、呼吸并发症和心脏并发症的发生率较低。
目前的证据支持血管腔内修复优于开放手术。然而,需要进行专门的随机对照试验,以有效比较和确定两种策略的益处和风险。